c248c85dafaa2167b3ad8e0ad76be7d4a9a05385
max
  Fri Oct 30 09:02:47 2020 -0700
lifting covid rare mutations to hg38 and polishing up the track a bit more, refs #26351

diff --git src/hg/makeDb/trackDb/human/covidHgeMuts.html src/hg/makeDb/trackDb/human/covidHgeMuts.html
deleted file mode 100644
index 303b490..0000000
--- src/hg/makeDb/trackDb/human/covidHgeMuts.html
+++ /dev/null
@@ -1,82 +0,0 @@
-<h2>Description</h2>
-<p>
-This track shows variants associated with monogenic congenital defects of immunity to <b>SARS-CoV-2</b>, 
-with incomplete or complete penetrance from the <a target=_blank 
-href="https://www.covidhge.com/">COVID Human Genetic Effort</a>. This international consortium aims 
-to detect rare or common monogenic inborn immunity errors (IEI) underlying severe forms of COVID-19 
-in previously healthy individuals, as well as rare or common monogenic variations that make certain 
-individuals resistant to infection by SARS-CoV2 virus despite repeated exposure.
-</p>
-
-<p>
-The major feature of the small set of  variants in this track is that they are functionally tested 
-to be <b>deleterious</b> and genetically tested to be <b>disease-causing</b>. Specifically, 
-rare variants were predicted to be loss-of-function (LOF) at 13 human loci known to govern 
-TLR3- and IRF7-dependent type I interferon (IFN) immunity to influenza virus in patients with 
-life-threatening COVID-19 pneumonia, relative to subjects with asymptomatic or benign infection. 
-These genetic defects display incomplete penetrance for influenza respiratory distress and only 
-manifested clinically upon infection with the more virulent SARS-CoV-2.
-</p>
- 
-<h2>Display Conventions</h2>
-<p>
-Unlike a regular genome browser track, the <b>COVID-19 Immunity Variants</b> track displays all
-affected genes in <a href="https://genome.ucsc.edu/goldenPath/help/multiRegionHelp.html">multi-region view</a>, 
-showing the variants within the coordinates of the gene, but hiding all the intergenic bases. To 
-return to the default Genome Browser view, click on the "-" button next to the "region" box.
-</p>
-<p>
-Only eight genes and few variants are contained in this track. Use the links below to browse the 
-the gene of interest:
-
-<dl>
-  <dd>Gene 1 chr:</dd>
-  <dd>Gene 2 chr:</dd>
-</dl>
-</p>
-
-<h2>Methods</h2>
-<p>
-Variant calls in 12 autosomal IFN-related genes from whole exome or genome data with a MAF lower 
-than 0.001 (gnomAD v2.1.1) and experimental demonstration of loss-of-function (LOF) were considered 
-for statistical analysis. The proportion of individuals carrying at least one pLOF variant was 
-compared between cases and controls by means of logistic regression with the likelihood ratio test. 
-The first three principal components of the PCA were included in the logistic regression model 
-to account for ethnic heterogeneity of the cohorts. 
-Analysis of enrichment in rare (MAF &lt 0.001) synonymous 
-variants of the 12 genes was performed to check the calibration of the burden test. PCA was 
-conducted with Plink v1.9 software on whole exome and genome sequencing data and 1000 Genomes (1kG) 
-Project phase 3 public database as reference, using 27,480 exonic variants with a minor allele 
-frequency &gt0.01 and a call rate &gt0.99. The odds ratio was also estimated by logistic regression 
-and adjusted for ethnic heterogeneity. 
-</p>
-
-<h2>Data Access</h2>
-<p>
-The raw data can be explored interactively with the <a target="_blank" href="../cgi-bin/hgTables">
-Table Browser</a>, or the <a target="_blank" href="../cgi-bin/hgIntegrator">Data Integrator</a>.
-Please refer to
-our <a href="https://groups.google.com/a/soe.ucsc.edu/forum/#!forum/genome"
-target="_blank">mailing list archives</a> for questions, or our <a target="_blank"
-href="../FAQ/FAQdownloads.html#download36">Data Access FAQ</a> for more information.
-</p>
-
-<h2>Credits</h2>
-<p>
-Thanks to the COVID Human Genetic Effort contributors for making these data available, and in 
-particular to Qian Zhang at the Rockefeller University for review and input during browser track 
-development.
-</p>
-
-
-<h2>References</h2>
-<p>
-Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C
-<em>et al</em>.
-<a href="https://www.ncbi.nlm.nih.gov/pubmed/32972995" target="_blank">
-Inborn errors of type I IFN immunity in patients with life-threatening COVID-19</a>.
-<em>Science</em>. 2020 Sep 24;.
-PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/32972995" target="_blank">32972995</a>
-</p> 
-
-